1. Home
  2. HURC vs GOSS Comparison

HURC vs GOSS Comparison

Compare HURC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$16.14

Market Cap

107.3M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.42

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
GOSS
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.3M
101.2M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
HURC
GOSS
Price
$16.14
$0.42
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
19.3K
10.5M
Earning Date
03-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$144.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.19
$0.32
52 Week High
$21.46
$3.87

Technical Indicators

Market Signals
Indicator
HURC
GOSS
Relative Strength Index (RSI) 58.48 36.93
Support Level $14.59 $0.33
Resistance Level $17.94 $0.60
Average True Range (ATR) 0.59 0.04
MACD 0.21 0.06
Stochastic Oscillator 79.29 86.88

Price Performance

Historical Comparison
HURC
GOSS

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: